EQUIC-SM: Enhancing Quality of Informed Consent

Sponsor
US Department of Veterans Affairs (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT00032565
Collaborator
(none)
836
22
64
38
0.6

Study Details

Study Description

Brief Summary

Patients in 'parent' cooperative studies projects are interviewed about their experiences in the informed consent process.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Intervention: Self-Monitoring Questionnaire (a questionnaire relating to the process of IC self-administered by study coordinators) and evaluation of the informed consent process using the Brief Informed Consent Evaluation Protocol (BICEP) developed during the EQUIC-DP phase.

    Primary Hypothesis: We hypothesize that by focusing attention on what may have become a routinized process, the quality of the IC encounter will be enhanced. We will evaluate the success of this intervention by having the patient-subject complete a telephone questionnaire, the BICEP (Brief Informed Consent Evaluation Protocol), after the IC process is completed.

    Primary Outcomes: The quality of the informed consent process, as measured by the BICEP (Brief Informed Consent Evaluation Protocol). The BICEP also offers a method to certify informed consent in routine use.

    Study Abstract: Enhancing the Quality of Informed Consent Self-Monitoring (EQUIC-SM) is one component of a VA Cooperative Studies Program-wide initiative on informed consent (EQUIC). Its objective is the field testing and iterative improvement of one intervention in the informed consent (IC) process, self monitoring. Self-monitoring involves having the person obtaining IC complete a Self-Monitoring Questionnaire, or SMQ after the IC encounter with a patient-subject being recruited for a participating study. We conceive of the SMQ as an activation device which prompts the person obtaining IC to monitor how he/she conducts the IC encounter. RESEARCH DESIGN: EQUIC-SM will be conducted in conjunction with participating clinical trials of the VA CSP at multiple VAs throughout the country. Patient-subjects will be recruited from among participants in these parent studies. Parent studies will be randomized to SM protocol or to control sites.

    METHODOLOGY: Patient-subjects will be informed about EQUIC-SM at the time that they are first presented with information about the parent study. The person obtaining consent will use a scripted description of EQUIC-SM. If the subject agrees, verbal consent for EQUIC-SM will be obtained. The same parent study informed consent process will be used for both the SM protocol and control arms of EQUIC-SM; however in the SM protocol arm, the person obtaining consent will complete the SMQ after the IC process. In both arms, patient-subjects will be asked to complete the BICEP interview after the parent study IC process is completed. FINDINGS: Investigators will use the results of EQUIC-SM to assess the value of the self-monitoring technique in improving the quality of informed consent. The premise is that focusing the attention of the person obtaining informed consent on the IC process will enhance the quality of the IC encounter, and thus of the informed consent obtained.

    SIGNIFICANCE: Practitioners of clinical trials have a responsibility to ensure that patients participation in research be informed and voluntary. This responsibility implies that we should strive continuously to improve the effectiveness of methods for informing prospective research volunteers about experimental studies, thereby enhancing the protection of their interests. If the self-monitoring technique tested in EQUIC-SM proves to enhance the quality of informed consent, this technique may be adapted for wider use in conducting clinical trials, thus representing an important step towards this goal.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    836 participants
    Time Perspective:
    Cross-Sectional
    Official Title:
    CSP #476SM - Enhancing Quality of Informed Consent (EQUIC-SM) Self-Monitoring
    Study Start Date :
    Nov 1, 2002
    Actual Primary Completion Date :
    Jul 1, 2007
    Actual Study Completion Date :
    Mar 1, 2008

    Arms and Interventions

    Arm Intervention/Treatment
    1

    No intervention. Telephone interview.

    Outcome Measures

    Primary Outcome Measures

    1. Interview: Telephone based assessment of informed consent [immediate]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    Depends on 'parent' study

    Exclusion Criteria:

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 VA Medical Center, Birmingham Birmingham Alabama United States 35233
    2 Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock No. Little Rock Arkansas United States 72114-1706
    3 VA Medical Center, Loma Linda Loma Linda California United States 92357
    4 VA Palo Alto Health Care System Palo Alto California United States 94304-1207
    5 VA Connecticut Health Care System (West Haven) West Haven Connecticut United States 06516
    6 Atlanta VA Medical and Rehab Center, Decatur Decatur Georgia United States 30033
    7 Edward Hines, Jr. VA Hospital Hines Illinois United States 60141-5000
    8 VA Medical Center, Lexington Lexington Kentucky United States 40502
    9 Southeast Veterans Healthcare System, New Orleans New Orleans Louisiana United States 70112
    10 VA Maryland Health Care System, Baltimore Baltimore Maryland United States 21201
    11 VA Medical Center, Jamaica Plain Campus Boston Massachusetts United States 02130
    12 VA Boston Healthcare System, Brockton Campus Brockton Massachusetts United States 02301
    13 John D. Dingell VA Medical Center, Detroit Detroit Michigan United States 48201
    14 VA Medical Center, Minneapolis Minneapolis Minnesota United States 55417
    15 VA Western New York Healthcare System at Buffalo Buffalo New York United States 14215
    16 VA Medical Center, Northport Northport New York United States 11768
    17 VA Medical Center, Durham Durham North Carolina United States 27705
    18 VA Medical Center, Cincinnati Cincinnati Ohio United States 45220
    19 VA Medical Center, Philadelphia Philadelphia Pennsylvania United States 19104
    20 VA North Texas Health Care System, Dallas Dallas Texas United States 75216
    21 Michael E. DeBakey VA Medical Center (152) Houston Texas United States 77030
    22 Hunter Holmes McGuire VA Medical Center Richmond Virginia United States 23249

    Sponsors and Collaborators

    • US Department of Veterans Affairs

    Investigators

    • Study Chair: Philip Lavori, PhD, VA Palo Alto Health Care System

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00032565
    Other Study ID Numbers:
    • 476SM
    First Posted:
    Mar 28, 2002
    Last Update Posted:
    Sep 24, 2010
    Last Verified:
    Sep 1, 2010

    Study Results

    No Results Posted as of Sep 24, 2010